← Back to Search

Care Coordination for Cardiovascular Prevention in Psoriatic Disease (CP3 Trial)

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male or female aged 40-75

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

CP3 Trial Summary

This trial aims to use a new program to help patients with psoriatic disease lower their risk of heart disease through better care.

Who is the study for?

This trial is for men and women aged 40-75 with psoriasis or psoriatic arthritis, who are currently under dermatology care. It's not open to those on prescription lipid-lowering meds, pregnant or planning pregnancy soon, or with a history of cardiovascular diseases like heart attack or stroke.Check my eligibility

What is being tested?

The study is testing a new 'care coordinator' program designed to help patients with psoriatic disease reduce their risk of developing cardiovascular disease by following standard healthcare practices to manage risk factors.See study design

What are the potential side effects?

Since the intervention involves standard care coordination rather than medication, direct side effects are not expected as in drug trials. However, changes in lifestyle or diet as part of the coordinated care may have individual health impacts.

CP3 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 75 years old.

CP3 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in LDL

Secondary outcome measures

30% LDL reduction

50% LDL reduction

Addition of new medication

+18 more

CP3 Trial Design

1Treatment groups

Experimental Treatment

Group I: Care CoordinationExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,881,767 Total Patients Enrolled

National Psoriasis FoundationOTHER

11 Previous Clinical Trials

1,362 Total Patients Enrolled

Media Library

Care Coordination Clinical Trial Eligibility Overview. Trial Name: NCT05908240 — N/A

Cardiovascular Disease Research Study Groups: Care Coordination

Cardiovascular Disease Clinical Trial 2023: Care Coordination Highlights & Side Effects. Trial Name: NCT05908240 — N/A

Care Coordination 2023 Treatment Timeline for Medical Study. Trial Name: NCT05908240 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial enlist individuals with an age of 45 years or more?

"Following the regulations of this trial, eligible participants must be between 40 and 75 years old."

Answered by AI

What are the requirements for potential participants in this experiment?

"To participate in this cardiovascular research, the requisite age range is between 40 and 75 years old. 520 patients will be permitted to join the trial."

Answered by AI

Does this research currently accept new participants?

"Affirmative. The information found on clinicaltrials.gov confirms that this study, which was first advertised on June 15th 2023 is currently recruiting subjects. A total of 520 patients are needed at a single medical centre."

Answered by AI

How many individuals are the maximum capacity for this medical study?

"Affirmative. Clinicaltrials.gov data suggests that the trial is currently recruiting participants, which began on June 15th 2023 and was most recently updated July 10th 2023. 520 individuals are needed to be recruited from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

2023. "Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05908240.

All > Psoriasis > Plaque Psoriasis